Nextgen Biomed Management

Management criteria checks 2/4

Nextgen Biomed's CEO is Harel Hershtik, appointed in Nov 2022, has a tenure of 2.25 years. total yearly compensation is ₪794.00K, comprised of 49.7% salary and 50.3% bonuses, including company stock and options. directly owns 3.73% of the company’s shares, worth ₪267.04K. The average tenure of the management team and the board of directors is 2.3 years and 2.2 years respectively.

Key information

Harel Hershtik

Chief executive officer

₪794.0k

Total compensation

CEO salary percentage49.7%
CEO tenure2.3yrs
CEO ownership3.7%
Management average tenure2.3yrs
Board average tenure2.2yrs

Recent management updates

Recent updates

We Think Nextgen Biomed (TLV:NXGN) Can Afford To Drive Business Growth

Aug 22
We Think Nextgen Biomed (TLV:NXGN) Can Afford To Drive Business Growth

Here's Why We're Not Too Worried About Nextgen Biomed's (TLV:NXGN) Cash Burn Situation

May 02
Here's Why We're Not Too Worried About Nextgen Biomed's (TLV:NXGN) Cash Burn Situation

We're Hopeful That Nextgen Biomed (TLV:NXGN) Will Use Its Cash Wisely

Jan 13
We're Hopeful That Nextgen Biomed (TLV:NXGN) Will Use Its Cash Wisely

CEO Compensation Analysis

How has Harel Hershtik's remuneration changed compared to Nextgen Biomed's earnings?
DateTotal CompensationSalaryCompany Earnings
Jun 30 2024n/an/a

-₪14m

Mar 31 2024n/an/a

-₪14m

Dec 31 2023₪794k₪395k

-₪14m

Compensation vs Market: Harel's total compensation ($USD223.76K) is below average for companies of similar size in the IL market ($USD418.00K).

Compensation vs Earnings: Insufficient data to compare Harel's compensation with company performance.


CEO

Harel Hershtik (49 yo)

2.3yrs

Tenure

₪794,000

Compensation

Mr. Harel Hershtik serves as CEO & GM of Nextgen Biomed Ltd since November 22, 2022.


Leadership Team

NamePositionTenureCompensationOwnership
Harel Hershtik
CEO & GM2.3yrs₪794.00k3.73%
₪ 267.0k
Dalia Mulakandov
CFO & VP of Finance2.1yrs₪612.29kno data
Anat Zimet
Legal Advisor & Company Secretary10.1yrs₪195.00kno data

2.3yrs

Average Tenure

Experienced Management: NXGN's management team is considered experienced (2.3 years average tenure).


Board Members

NamePositionTenureCompensationOwnership
Yaakov Amidror
Chairman of the Board4.1yrs₪524.00k2.78%
₪ 198.6k
Jacob Kaul
Director2.3yrsno data1.56%
₪ 111.9k
Alon Pinkas
Director2.3yrsno datano data
Ilana Eldan
Director2.2yrsno datano data
Hila Hameldig
Independent Outside Director1.5yrsno datano data
Israel Shatelberg
Independent Outside Director1.5yrsno datano data

2.2yrs

Average Tenure

53.5yo

Average Age

Experienced Board: NXGN's board of directors are not considered experienced ( 2.2 years average tenure), which suggests a new board.


Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/02/16 08:27
End of Day Share Price 2025/02/13 00:00
Earnings2024/06/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Nextgen Biomed Ltd is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.